KALTF Stock Price, News & Analysis
Company Description
KALTF (OTC: KALTF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.3M.
KALTF stock has declined 27.3% over the past year.
This page provides a comprehensive overview of KALTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
KALTF (KALTF) stock. Over the past 12 months, the stock has lost 27.3%. At a market capitalization of $4.3M, KALTF is classified as a micro-cap stock with approximately 35.5M shares outstanding.
Latest News
KALTF has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial, acquisition. View all KALTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
KALTF Company Profile & Sector Positioning
KALTF (KALTF) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing KALTF often look at related companies in the same sector, including Quoin Pharmaceuticals Ltd (QNRX), Jaguar Health Inc (JAGX), Azitra Inc (AZTR), CNS Pharmaceuticals (CNSP), and Xortx Therapeutics Inc (XRTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KALTF's relative position within its industry.